6 completed. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 2 | Completed 2 |
Follow Urinary Retention: new trials by email Literature Review of Urinary Retention trials Research Report on Urinary Retention
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery Placebo oral capsule, Tamsulosin - Urinary Retention, Lower Urinary Tract Symptoms | Phase 2 / Phase 3 | Completed | University Hospitals Cleveland Medical Center | 132 | 2018-08-01 | 2021-11-08 |
| Effect of Active vs. Passive Voiding Trials on Time to Discharge, Urinary Tract Infection, and Urinary Retention Active Voiding Trial, Passive Voiding Trial - Urinary Retention, Urinary Tract Infections | Phase 3 | Completed | University of Virginia | 274 | 2015-10-01 | 2016-09-01 |
| Prevention of Post-operative Urinary Retention Tamsulosin, Placebo - Urinary Retention, Urinary Tract Infections | Phase 3 | Completed | University of Wisconsin, Madison | 158 | 2015-08-01 | 2019-09-25 |
| Botulinum Toxin A Injections in Patients With Fowler's Syndrome onabotulinumtoxinA - Urinary Retention, Fowler's Syndrome | Phase 2 / Phase 3 | Completed | University College, London | 10 | 2009-11-01 | 2015-04-29 |
| Prevention of Acute Voiding Difficulty After Radical Proctectomy Tamsulosin - Rectal Cancer, Urinary Retention | Phase 3 | Completed | Seoul National University Hospital | 100 | 2007-05-01 | 2011-07-20 |
| Clinical Trial in Males With BPH (Enlarged Prostate) Alfuzosin (SL770499) - Urinary Retention, Prostatic Hyperplasia | Phase 3 | Completed | Sanofi | 1522 | 2001-05-01 | 2008-06-09 |
Urinary Tract Infections (2) · Catheter-Related Infections (1) · Fowler Christmas Chapple syndrome (1) · Lower Urinary Tract Symptoms (1) · Pelvic Organ Prolapse (1) · Postoperative Complications (1) · Prostatic Hyperplasia (1) · Rectal Neoplasms (1) · Urinary Incontinence, Stress (1)
Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Male Urogenital Diseases (6) · Urination Disorders (6) · Urogenital Diseases (6) · Urologic Diseases (6) · Infections (2) · Pathological Conditions, Signs and Symptoms (2) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genital Diseases (1) · Genital Diseases, Male (1)
Tamsulosin (3) · Botulinum Toxins, Type A (1) · alfuzosin (1)
Sanofi (1) · Seoul National University Hospital (1) · University College, London (1) · University Hospitals Cleveland Medical Center (1) · University of Virginia (1) · University of Wisconsin, Madison (1)
United States (3) · Australia (1) · Bulgaria (1) · Canada (1) · Denmark (1) · Finland (1) · Greece (1) · Hungary (1) · Israel (1) · Netherlands (1) · Norway (1) · Poland (1) · Portugal (1) · Romania (1) · South Africa (1)
Evie H Carchman, MD (1) · Graham Chapman (1) · Sung-Bum Kang, M.D., Ph.D (1) · Tracey L Krupski, MD, MPH (1)
PMID 11743295, PMID 15291863, PMID 16536764, PMID 31732771, PMID 33894146, PMID 34184246